---
title: About Us - Eyerising International
description: Learn about Eyerising International, an Australian MedTech company advancing repeated low-level red-light (RLRL) therapy for childhood myopia management across 30+ countries.
image: https://eyerisinginternational.com/hubfs/eri-web/images/og-default.png
---

I am not an eye-care professional I am an eye-care professional

 Viewing the International site.

[![Eyerising International](https://eyerisinginternational.com/hubfs/eri-web/logo-white.png)](https://eyerisinginternational.com/?hsLang=en)

[Home](https://eyerisinginternational.com/?hsLang=en)

[About Us](https://eyerisinginternational.com/about?hsLang=en)

[About Eyerising](https://eyerisinginternational.com/about?hsLang=en) [Our Story](https://eyerisinginternational.com/story?hsLang=en) [Purpose, Mission & Values](https://eyerisinginternational.com/purpose?hsLang=en) [Our Team](https://eyerisinginternational.com/team?hsLang=en) [What is Myopia?](https://eyerisinginternational.com/myopia?hsLang=en) [Meet Willow](https://eyerisinginternational.com/willow?hsLang=en)

[Our Device](https://eyerisinginternational.com/device?hsLang=en)

[Our Device](https://eyerisinginternational.com/device?hsLang=en) [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) [Regulatory](https://eyerisinginternational.com/regulatory?hsLang=en)

[News](https://eyerisinginternational.com/news?hsLang=en)

[Latest News](https://eyerisinginternational.com/news?hsLang=en) [Clinical Information](https://eyerisinginternational.com/clinical-info?hsLang=en) 

[Events](https://eyerisinginternational.com/events?hsLang=en)

[Contact](https://eyerisinginternational.com/contact?hsLang=en)

[Contact Us](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) [FAQs](https://eyerisinginternational.com/faqs?hsLang=en)

[Get in Touch](https://eyerisinginternational.com/contact?hsLang=en)

[Home](https://eyerisinginternational.com/?hsLang=en) [About Us](https://eyerisinginternational.com/about?hsLang=en) [Our Story](https://eyerisinginternational.com/story?hsLang=en) [Purpose, Mission & Values](https://eyerisinginternational.com/purpose?hsLang=en) [Our Team](https://eyerisinginternational.com/team?hsLang=en) [What is Myopia?](https://eyerisinginternational.com/myopia?hsLang=en) [Meet Willow](https://eyerisinginternational.com/willow?hsLang=en) [Our Device](https://eyerisinginternational.com/device?hsLang=en) [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) [Regulatory Approval](https://eyerisinginternational.com/regulatory?hsLang=en) [News](https://eyerisinginternational.com/news?hsLang=en) [Clinical Information](https://eyerisinginternational.com/clinical-info?hsLang=en) [Events](https://eyerisinginternational.com/events?hsLang=en) [Contact Us](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) [FAQs](https://eyerisinginternational.com/faqs?hsLang=en) [Get in Touch](https://eyerisinginternational.com/contact?hsLang=en)

# About Eyerising International

 An Australian-based MedTech company pioneering repeated low-level red-light technology for childhood myopia management.

## Who We Are

 Eyerising International is an Australian MedTech company developing RLRL therapy for the management of childhood myopia in patients aged 3–16 years old. Our work is guided by leading ophthalmology researchers and clinicians, with a focus on innovation, implementation, and clinical validation.

 The Eyerising Myopia Management Device delivers RLRL therapy, and was conceived and developed by our Chief Medical Officer, Professor Mingguang He—a globally recognised researcher in myopia control and the development of artificial intelligence systems in ophthalmology.

 The device is patented and registered on the Australian Register of Therapeutic Goods (ARTG 412752). Today, Eyerising International operates across more than 40 countries, partnering with eye-care professionals worldwide.

 Eyerising International is an Australian MedTech company dedicated to innovation in children's vision. Our work is guided by experts in ophthalmology, optometry, and medical technology.

 Eyerising International has fostered partnerships with universities and research institutions worldwide, and our patented technology is listed on the Australian Register of Therapeutic Goods (ARTG 412752).

 Today, we operate across more than 40 countries, working with eye-care professionals to deliver accessible, evidence-based myopia management to children and families globally.

Patented Technology ARTG 412752 40+ Countries

![Child receiving Eyerising RLRL therapy](https://eyerisinginternational.com/hubfs/eri-web/images/about-myopia.jpg)

## What Drives Us

### Innovation

 We continuously advance RLRL technology, investing in research and development to improve outcomes for children with myopia and deliver a superior patient experience.

### Clinical Excellence

 Every decision we make is grounded in scientific evidence. We uphold the highest clinical standards across our research, regulatory submissions, and clinical partnerships.

### Global Access

 We believe every child deserves access to effective myopia management. Our global distribution network and partnerships with eye-care professionals make this vision a reality.

## By the Numbers

40+

Countries

1,500+

Active Patients Internationally

20+

Clinical Trials

## Join Us in Advancing Myopia Management

 Whether you are a clinician, distributor, or family seeking solutions, we would love to hear from you. 

[Contact Us](https://eyerisinginternational.com/contact?hsLang=en)

![Eyerising International](https://eyerisinginternational.com/hubfs/eri-web/logo-white.png)

 Advancing myopia management through repeated low-level red-light therapy.

#### Company

- [About Us](https://eyerisinginternational.com/about?hsLang=en)
- [Our Team](https://eyerisinginternational.com/team?hsLang=en)
- [Our Story](https://eyerisinginternational.com/story?hsLang=en)
- [News](https://eyerisinginternational.com/news?hsLang=en)
- [Events](https://eyerisinginternational.com/events?hsLang=en)

#### Resources

- [Our Device](https://eyerisinginternational.com/device?hsLang=en)
- [Safety Information](https://eyerisinginternational.com/safety?hsLang=en)
- [Regulatory Approval](https://eyerisinginternational.com/regulatory?hsLang=en)
- [FAQs](https://eyerisinginternational.com/faqs?hsLang=en)
- [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en)

#### Contact

 Suite 2.05, 9/11 Claremont St  
 South Yarra VIC 3141, Australia 

[info@eyerisinginternational.com](mailto:info@eyerisinginternational.com)

[LinkedIn](https://au.linkedin.com/company/eyerising-international)

THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE

Ask your optometrist or ophthalmologist for advice to see if this product is right for your child.

Outcomes may vary for each patient. The Eyerising Myopia Management Device is exclusively available through eye care professionals (e.g. optometrists, ophthalmologists) for home use.

© 2026 Eyerising International. All rights reserved.

[LinkedIn](https://au.linkedin.com/company/eyerising-international) [Privacy Policy](https://eyerisinginternational.com/legal?hsLang=en) [Terms & Conditions](https://eyerisinginternational.com/legal?hsLang=en)

## Welcome to Eyerising International

To show you the most relevant information, please confirm which best describes you.

I am not an Eye-Care Professional

I am an Eye-Care Professional

## Disclaimer

This website is intended for use by eye care professionals only. By agreeing and proceeding, you are declaring you are a registered eye care professional. If you are not a registered eye care professional, do not proceed.

I Agree

I Disagree

```json
{
  "@context" : "https://schema.org",
  "@type" : "MedicalOrganization",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "AU",
    "addressLocality" : "South Yarra",
    "addressRegion" : "VIC",
    "postalCode" : "3141",
    "streetAddress" : "Suite 2.05, 9/11 Claremont St"
  },
  "contactPoint" : {
    "@type" : "ContactPoint",
    "contactType" : "customer service",
    "email" : "info@eyerisinginternational.com"
  },
  "description" : "Australian MedTech company advancing repeated low-level red-light (RLRL) therapy for childhood myopia management.",
  "foundingDate" : "2020",
  "logo" : "https://43619611.fs1.hubspotusercontent-ap1.net/hubfs/43619611/eri-web/logo-white.png",
  "name" : "Eyerising International",
  "sameAs" : [ "https://www.linkedin.com/company/eyerising-international" ],
  "url" : "https://eyerisinginternational.com"
}
```